Compute Health Acquisitio... (CPUH)
Compute Health Acquisition Statistics
Share Statistics
Compute Health Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.22M |
| Failed to Deliver (FTD) Shares | 25 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 6.73 and the forward PE ratio is null. Compute Health Acquisition's PEG ratio is 0.01.
| PE Ratio | 6.73 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 2.53 |
| P/FCF Ratio | -68.88 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Compute Health Acquisition has an Enterprise Value (EV) of 217.95M.
| EV / Sales | 0 |
| EV / EBITDA | -4.96 |
| EV / EBIT | -68.93 |
| EV / FCF | -68.93 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.01.
| Current Ratio | 0.74 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.29 |
| Interest Coverage | 0.12 |
Financial Efficiency
Return on Equity is 37.58% and Return on Invested Capital is -5.05%.
| Return on Equity | 37.58% |
| Return on Assets | 33.95% |
| Return on Invested Capital | -5.05% |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2.17M |
| Effective Tax Rate | 6.27% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 0.02, so Compute Health Acquisition's price volatility has been higher than the market average.
| Beta | 0.02 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 10.58 |
| 200-Day Moving Average | 10.28 |
| Relative Strength Index (RSI) | 40.9 |
| Average Volume (20 Days) | 57.58K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -4.69M |
| Net Income | 32.37M |
| EBITDA | -43.91M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 0.4 |
Balance Sheet
The company has 765.78K in cash and 932.01K in debt, giving a net cash position of -166.23K.
| Cash & Cash Equivalents | 765.78K |
| Total Debt | 932.01K |
| Net Cash | -166.23K |
| Retained Earnings | -8.27M |
| Total Assets | 96.96M |
| Working Capital | -2.8M |
Cash Flow
In the last 12 months, operating cash flow was -3.16M and capital expenditures 0, giving a free cash flow of -3.16M.
| Operating Cash Flow | -3.16M |
| Capital Expenditures | 0 |
| Free Cash Flow | -3.16M |
| FCF Per Share | -0.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CPUH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 14.86% |
| FCF Yield | -1.45% |
Analyst Forecast
Currently there are no analyst rating for CPUH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 7.29 |
| Piotroski F-Score | 4 |